496 related articles for article (PubMed ID: 27094782)
1. Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine.
Lesniak A; Bochynska-Czyz M; Sacharczuk M; Benhye S; Misicka A; Bujalska-Zadrozny M; Lipkowski AW
Eur J Pharm Sci; 2016 Jun; 89():39-49. PubMed ID: 27094782
[TBL] [Abstract][Full Text] [Related]
2. Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice.
Shinohara A; Andoh T; Saiki I; Kuraishi Y
Eur J Pharmacol; 2018 Aug; 833():275-282. PubMed ID: 29886241
[TBL] [Abstract][Full Text] [Related]
3. Biphalin, an enkephalin analog with unexpectedly high antinociceptive potency and low dependence liability in vivo, selectively antagonizes excitatory opioid receptor functions of sensory neurons in culture.
Shen KF; Crain SM
Brain Res; 1995 Dec; 701(1-2):158-66. PubMed ID: 8925279
[TBL] [Abstract][Full Text] [Related]
4. Glutamate Buffering Capacity and Blood-Brain Barrier Protection of Opioid Receptor Agonists Biphalin and Nociceptin.
Nozohouri S; Zhang Y; Albekairi TH; Vaidya B; Abbruscato TJ
J Pharmacol Exp Ther; 2021 Nov; 379(3):260-269. PubMed ID: 34663677
[TBL] [Abstract][Full Text] [Related]
5. Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?
Redkiewicz P; Dyniewicz J; Misicka A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768778
[TBL] [Abstract][Full Text] [Related]
6. Endomorphin-1 analogues (MELs) penetrate the blood-brain barrier and exhibit good analgesic effects with minimal side effects.
Wang Y; Liu X; Wang D; Yang J; Zhao L; Yu J; Wang R
Neuropharmacology; 2015 Oct; 97():312-21. PubMed ID: 26116761
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro.
Lazarczyk M; Matyja E; Lipkowski AW
Peptides; 2010 Aug; 31(8):1606-12. PubMed ID: 20580757
[TBL] [Abstract][Full Text] [Related]
8. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin.
Kosson D; Klinowiecka A; Kosson P; Bonney I; Carr DB; Mayzner-Zawadzka E; Lipkowski AW
Eur J Pain; 2008 Jul; 12(5):611-6. PubMed ID: 18068383
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
Horan PJ; Mattia A; Bilsky EJ; Weber S; Davis TP; Yamamura HI; Malatynska E; Appleyard SM; Slaninova J; Misicka A
J Pharmacol Exp Ther; 1993 Jun; 265(3):1446-54. PubMed ID: 8389867
[TBL] [Abstract][Full Text] [Related]
11. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
12. Pluronic p85 block copolymer enhances opioid peptide analgesia.
Witt KA; Huber JD; Egleton RD; Davis TP
J Pharmacol Exp Ther; 2002 Nov; 303(2):760-7. PubMed ID: 12388663
[TBL] [Abstract][Full Text] [Related]
13. Methadone antinociception is dependent on peripheral opioid receptors.
He L; Kim J; Ou C; McFadden W; van Rijn RM; Whistler JL
J Pain; 2009 Apr; 10(4):369-79. PubMed ID: 19327642
[TBL] [Abstract][Full Text] [Related]
14. A new potent analgesic agent with reduced liability to produce morphine tolerance.
Kiraly K; Caputi FF; Hanuska A; Kató E; Balogh M; Köles L; Palmisano M; Riba P; Hosztafi S; Romualdi P; Candeletti S; Ferdinandy P; Fürst S; Al-Khrasani M
Brain Res Bull; 2015 Aug; 117():32-8. PubMed ID: 26235542
[TBL] [Abstract][Full Text] [Related]
15. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
Negri L; Lattanzi R; Melchiorri P
Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non-hydrazine linker.
Mollica A; Costante R; Stefanucci A; Pinnen F; Lucente G; Fidanza S; Pieretti S
J Pept Sci; 2013 Apr; 19(4):233-9. PubMed ID: 23136069
[TBL] [Abstract][Full Text] [Related]
17. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice.
Tejada MA; Montilla-García A; Cronin SJ; Cikes D; Sánchez-Fernández C; González-Cano R; Ruiz-Cantero MC; Penninger JM; Vela JM; Baeyens JM; Cobos EJ
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8396-8401. PubMed ID: 28716934
[TBL] [Abstract][Full Text] [Related]
18. The analgesic activity of biphalin and its analog AM 94 in rats.
Leone S; Chiavaroli A; Orlando G; Mollica A; Di Nisio C; Brunetti L; Vacca M
Eur J Pharmacol; 2012 Jun; 685(1-3):70-3. PubMed ID: 22546229
[TBL] [Abstract][Full Text] [Related]
19. Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain.
Khalefa BI; Mousa SA; Shaqura M; Lackó E; Hosztafi S; Riba P; Schäfer M; Ferdinandy P; Fürst S; Al-Khrasani M
Eur J Pharmacol; 2013 Aug; 713(1-3):54-7. PubMed ID: 23665110
[TBL] [Abstract][Full Text] [Related]
20. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
Vaught JL; Mathiasen JR; Raffa RB
J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
